Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
Clinical, functional and therapeutic analysis of CD99 in acute myeloid leukemia
PDF
Investigation of the synergistic effect of midostaurin, a tyrosine kinase inhibitor, with anti FLT3 antibodies-based therapies for acute myeloid leukemia
PDF
Characterization of upregulated adhesion GPCRs in acute myeloid leukemia
PDF
Role of apolipoprotein C2 in acute myeloid leukemia: clinical, functional and mechanistic study
PDF
Characterization of epithelial-mesenchymal transition in acute myeloid leukemia
PDF
Reprogramming exosomes for immunotherapy of acute myeloid leukemia
PDF
Investigating CD99 as a therapeutic target in acute myeloid leukemia
PDF
Youth Day, Hollywood Bowl, 1951
Systems pharmacology for acute myeloid leukemia and feedback control pharmacodynamic models
PDF
Application of elastin-like polypeptides to therapeutics in leukemia
PDF
I. Microwave-assisted synthesis of phosphonic acids; II. Design and synthesis of polymerase β lyase domain inhibitors
PDF
Mayor leaves for Chicago, 1952
Study of the role of bone morphogenetic proteins in prostate cancer progression
PDF
Loss of checkpoint controls in acute lymphoblastic leukemia
PDF
The role of survivin in drug resistant pediatric acute lymphoblastic leukemia
PDF
Maternal embryonic leucine zipper kinase (MELK) as a novel therapeutic target in the treatment of acute lymphoblastic leukemia
PDF
Investigating the effects of T cell mediated anti-leukemia activity in FLT3-ITD positive acute myeloid leukemia
PDF
Deregulation of CD36 expression in cancer presents a potential targeting therapeutic opportunity
PDF
Youth Day, Hollywood Bowl, 1951
Youth Day, Hollywood Bowl, 1951
Youth Day, Hollywood Bowl, 1951
Youth Day, Hollywood Bowl, 1951
Youth Day, Hollywood Bowl, 1951
Youth Day, Hollywood Bowl, 1951
of 3